Another interesting study: ascopubs.org... - SHARE Metastatic ...

SHARE Metastatic Breast Cancer

6,811 members8,427 posts

Another interesting study

Hazelgreen profile image
6 Replies

ascopubs.org/doi/10.1200/JC...

"Using the Danish Breast Cancer Group and other nationwide databases, we identified women with early or late BC recurrence during 2004-2018, who were alive 6 months after recurrence. We followed them until BC death, death from other causes, emigration, 10 years, or December 31, 2018, whichever came first."

RESULTS

"Among 2,004 patients with late recurrence, 721 died of BC with a median survival time of 10 years (MR = 84.8 per 1,000 PY; 10-year cumulative mortality = 50%). Among 1,528 patients with early recurrence, 1,092 BC deaths occurred with a median survival time of 4 years (MR = 173.9 per 1,000 PY; 10-year cumulative mortality = 72%)."

"Advanced stage at primary diagnosis, distant metastases, adjuvant treatment for locoregional recurrence, and systemic treatment for distant recurrence were associated with increased mortality after late recurrence. Breast-conserving surgery at primary diagnosis, locoregional recurrence, and surgery for recurrence were associated with lower mortality after late recurrence."

CONCLUSION

"Patients with late recurrence had more favorable prognosis than patients with early recurrence. The localization of recurrent disease was the main prognostic factor for BC death."

Written by
Hazelgreen profile image
Hazelgreen
To view profiles and participate in discussions please or .
Read more about...
6 Replies
Hazelgreen profile image
Hazelgreen

Please note the long median survival time for "late recurrance" - 10 years! Half of the women lasted more than 10 years with late recurrence MBC!

Pbsoup profile image
Pbsoup in reply toHazelgreen

How is late recurrence defined?

Hazelgreen profile image
Hazelgreen in reply toPbsoup

In this Danish study, late recurrence was defined as 10 or more years after a BC diagnosis. Please see the link given above.

Regards,

Cindy

Bettybuckets profile image
Bettybuckets

Thanks for sharing!

Adele_Julia profile image
Adele_Julia

Well I got a reoccurrence in a year after my initial diagnosis. I wonder if my surgeon who did the lumpectomy in 2019 did t get the margins after all. I had surgery in 2019 followed by 8’rou da of chemo and another surgery only to have it come back Nov 2020 as MBC to pleura

RLN-overcomer profile image
RLN-overcomer

Sister/warrior/advocate thank you for this study information comparing early recurrence, as opposed to late recurrence of breast cancer. Interesting statistics. Thank you 😇

Not what you're looking for?

You may also like...

Trastuzumab Deruxtecan Extends Survival Over Chemotherapy for Patients With HER2-Positive Metastatic Breast Cancer

Trastuzumab deruxtecan (T-DXd) was associated with higher response rates and longer survival than...
Hazelgreen profile image

Good News re: CDK4/6 Inhibitors & Overall Survival

Greetings, If you have Hormone Receptor positive, HER2 negative MBC, some great news was shared...
Bestbird profile image

Updated Female Breast Cancer Statistics in the United States.

Published in Oncology News · October 05, 2022 TUESDAY, Oct. 4, 2022 (HealthDay News) -- The...
Hazelgreen profile image

Interesting Study of Cancer Fatique?

The following study is available in J. Clin. Oncol · April 05, 2022: "Long-Term Longitudinal...
Hazelgreen profile image

From Oncology 2022 Nov 11: "Acupuncture Reduces Aromatase Inhibitor-Related Joint Pain"

Although this study used early breast cancer patients, I assume the findings would also apply to...
Hazelgreen profile image

Moderation team

See all
Jslanovich profile image
JslanovichAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.